학술논문

Rindopepimut with bevacizumab for patients with relapsed EGFRvIII-expressing glioblastoma (REACT): Results of a double-blind randomized phase II trial
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 April 2020, 26(7):1586-1594)
Subject
Language
English
ISSN
15573265
10780432